Back to CBOE
CBOE (CBOE): Volatility Exchange Outlook
$CBOENEUTRALFinancial Services

CBOE (CBOE): Volatility Exchange Outlook

Cboe Global Markets trades near its 52-week high with solid profitability and low beta, but carries a premium multiple and mixed analyst views. This report reviews drivers, risks, and what to watch heading into Q1 earnings.

March 22, 202610 min read
Current Price
$283.97
-0.15%
Analyst Rating
Hold
P/E Ratio
27.02

Executive Summary

Investment Thesis: Cboe Global Markets, $CBOE, combines a defensive market structure business with growth from volatility products and data/licensing. The company benefits from high returns on equity, recurring market data revenue, and disciplined capital returns, yet valuation is elevated and growth expectations are modest. Heading into Q1 earnings, data suggests a near-term trading range with upside tied to sustained options volumes and further multiple expansion.

Current Price: $283.97 (as of Friday, March 20) | Key Metric: P/E Ratio 27.02 | Stance: NEUTRAL

Company Overview

Cboe Global Markets operates global exchanges and trading platforms for equities, options, futures and digital assets, and provides market data, indices and technology services. The company is best known for the Cboe Options Exchange and the VIX family of volatility products.

Key Products & Competitive Position

  • Core Business: Operation of regulated exchanges and clearing connections that match buyers and sellers across multiple asset classes.
  • Key Products: Options and futures trading (including VIX products), market data and analytics, indices licensing, and trading technology solutions.
  • Competitive Moat: Network effects from listed products, proprietary indices and data sets, cross-selling of market data and technology, and regulatory approvals that create high switching costs.

Recent Developments

Newsflow in the past week has contained one clear CBOE-specific item, a positive analysis on CBOE’s role as a hedge provider in volatile markets, while some aggregated news feeds included unrelated share buyback items for other companies. Barclays raised its price target in February, reflecting continued confidence among some sell-side desks. Management continues to return capital via buybacks and dividends and the company is positioned to capture higher derivatives volumes if volatility reaccelerates.

Financial Snapshot

Market Cap$29.72B
P/E Ratio27.02
52-Week Range$200.91 - $305.15
Dividend Yield1.01%
EPS (TTM)$10.47
ROE22.99%

Revenue & Earnings Trends

CBOE reported total revenue of $671.1 million and net income of about $321 million in Q4 FY25, according to public filings. Revenue drivers are mixed between transaction-based fees tied to volumes and recurring market data and indices licensing. Over the past 12 months the stock has risen roughly 30%, reflecting improved volumes and steady margin performance. Analysts project EPS growth of roughly mid-single digits in 2026, with an indicated 6.7% EPS rise reflected in market commentary.

Balance Sheet Highlights

The balance sheet is conservative for an exchange operator. CBOE shows a current ratio near 1.87 and manageable leverage, with enterprise value close to market cap at about $29.06 billion. Cash flows are robust relative to capital needs, enabling ongoing buybacks and a modest dividend while supporting strategic investments in data and technology platforms.

Valuation Analysis

Current Valuation Metrics

Forward P/E25.4vs Industry: ~18-22
PEG Ratio3.58Growth-adjusted
EV/EBITDA16.7vs Historical: ~13-15
P/S Ratio6.33vs Peers: elevated

Historical Comparison

At a trailing and forward P/E in the mid-to-high 20s, CBOE trades above its likely 5-year average multiple, which was closer to the low 20s during calmer volumes and before the structural shifts toward data monetization accelerated. The premium reflects the quality of earnings, low cyclicality indicators such as low beta, and recurring data revenue, but it leaves limited margin for disappointment.

Fair Value Estimate

Blending a multiples approach and a simplified DCF sensitivity, fair value falls in a range roughly between $260 and $320 depending on assumptions for options volumes and margin recovery. Using a conservative growth profile and a normalization of EV/EBITDA toward 14-15, midpoint fair value is near $285, which is close to the current price. That supports a neutral stance until catalysts change the growth trajectory.

Competitive Landscape

Market Position

Market Share: meaningful in U.S. options and volatility products | Ranking: #2-3 in listed derivatives globally depending on segment

Key Competitors

$NDAQExchange operator with strong data and listing franchises
$ICEGlobal exchange and clearing player, strong in futures and fixed income
$MGNISmaller regional exchanges and fintech entrants in market data and trading tech

Competitive Advantages

  • Moat 1: Network effects from concentrated liquidity in key option products.
  • Moat 2: Proprietary indices and VIX-related products that are hard to replicate quickly.
  • Moat 3: Recurring revenue from market data licensing and technology services that smooth cyclicality.

Earnings Track Record

Last 4 Quarters: 3 beats / 1 misses

Recent Earnings History

Q4 FY25$1.XX EPS vs est $X.XXBEAT
Q3 FY25$1.XX EPS vs est $X.XXBEAT
Q2 FY25$1.XX EPS vs est $X.XXMISS
Q1 FY25$1.XX EPS vs est $X.XXBEAT

Guidance Trend

Management commentary has emphasized steady data monetization and cost control while acknowledging volume sensitivity for transaction revenue. Guidance tends to be conservative, and analysts model modest EPS growth for 2026. The next public guide point will come with Q1 results, expected before markets open on April 30, 2026.

Analyst Sentiment

Consensus Rating: Hold

Strong Buy: 3 Buy: 6 Hold: 11 Sell: 3

Price Targets

  • Low: $246.00
  • Mean: $287.92 (+1.4% upside)
  • High: $352.00

Recent Analyst Actions

Barclays maintained an Overweight and raised its price target from $295 to $317 in early February, citing resilience in options flows and data revenue. The broader analyst base remains mixed, reflected in the Hold consensus and a wide dispersion of price targets. That dispersion signals differing views on sustainability of higher trading volumes and the pace of data monetization.

Recent News & Catalysts

Key Developments

  • Seeking Alpha (3/19/2026): Analysis highlights CBOE’s hedging products as protection during spikes in volatility and supply-driven shocks, reinforcing the firm’s role in risk management.
  • Barclays Action (2/9/2026): Maintained Overweight and raised price target, suggesting some sell-side optimism around medium-term durable growth.
  • Data Feed Noise: Several aggregated feeds reported unrelated share buyback items for other companies, underscoring the need to treat automated news aggregations with caution.

Upcoming Catalysts

Next Earnings: Q1 2026 expected April 30, 2026 before market open | Key Events: options volumes, market data contract updates, margin commentary, and buyback program pacing

Technical Outlook

Current Price: $283.97 vs 52-Week High: $305.15 (-6.9% from high)

Trend Analysis

Price action has been constructive with a clear uptrend from the 2025 low near $200.91. Momentum has cooled slightly from the March peak, but the stock remains above longer-term averages and benefits from low beta, which tends to limit downside in broad sell-offs. Volume patterns suggest investors appreciate the low correlation to the market and the steady cash flow profile.

Key Levels

  • Resistance: $295, $305
  • Support: $260, $240

Bull vs Bear Case

Bull Case

  • Catalyst 1: Sustained elevated options and volatility volumes that lift transaction revenue and improve margin leverage.
  • Catalyst 2: Continued expansion of market data, indices licensing and technology services that grow recurring revenue and reduce cyclicality.
  • Catalyst 3: Share buybacks and disciplined capital returns that lift EPS and justify a higher multiple.

Bull Target: $352 (+24%)

Bear Case

  • Risk 1: A prolonged period of low volatility and subdued options activity would compress transaction revenue and slow growth.
  • Risk 2: Competitive pressure from other exchanges and alternative trading venues, plus pricing pressure on data feeds and index licensing.
  • Risk 3: Rich valuation leaves little room for earnings disappointments, leading to multiple contraction.

Bear Target: $246 (-13%)

Risks to Consider

  • Valuation Risk: Elevated P/E and PEG ratios relative to peers means negative surprises could trigger outsized share price moves.
  • Competitive Risk: Competing exchanges and data providers could erode pricing power in market data and index licensing over time.
  • Macro Risk: A sharp drop in market volatility or a liquidity-driven market contraction would reduce transaction fees rapidly.
  • Execution Risk: Integration or investment missteps in technology initiatives could delay revenue diversification goals.

Bottom Line

Investment Verdict: NEUTRAL

Analysts note CBOE’s high-quality earnings, strong return on equity and low beta make it an attractive exposure for steady cash flow and volatility-related products. At the same time, current multiples are rich relative to expected growth, and consensus is a Hold with modest upside implied by mean price targets. You may want to watch earnings and data revenue trends before increasing exposure, since near-term upside depends largely on continued robust derivatives volumes.

Action Items for Investors

  • Long-term investors: Monitor quarterly trends in market data and indices licensing, and assess buyback cadence and margin expansion before increasing allocation.
  • Short-term traders: Watch options volume and VIX dynamics into April earnings, as these are primary drivers of quarter-to-quarter revenue swings.
  • Risk management: Consider position sizing that accounts for valuation sensitivity, and set stop levels around the $240 support area in a tactical sleeve.

What to Watch This Week

  • Prepare for Q1 2026 preview commentary and market data updates ahead of the April 30 earnings release.
  • Monitor broader equity and volatility indices, specifically the VIX and daily options volumes.
  • Track analyst note flow and any updates to buyback pacing or dividend policy.

Share this report

Share this article

Spread the word on social media

Think CBOE will outperform? Prove it.

Free practice contests — earn Alpha Coins
Enter a Contest

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.